Trial NCT01459913

View at ClinicalTrials.gov 
Org. Study IDs: VX11-950-114

Last trial update was posted on 2015-06-10

MeSH Interventions

Interferon alpha-2 Interferon-alpha Interferons Peginterferon alfa-2a Ribavirin

MeSH Conditions

Hepatitis Hepatitis C Hepatitis C, Chronic

Other Conditions


Stopping Reasons

The study was terminated early by the sponsor on 13 January 2014 due to a decision to modify the drug development plan.

Limitations And Caveats

The study was terminated early at the primary efficacy endpoint (SVR12), by the sponsor on 13 January 2014 due to a decision to modify the drug development plan.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID